Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 10, 2013British Journal of Dermatology

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

View Full Paper
Ask AI
Bookmark
Share

Authors

Kim Papp
Kim PappUniversity of Toronto
C.E.M. Griffiths
C.E.M. GriffithsRutgers, The State University of New JerseyKGKenneth B. GordonMedical College of Wisconsin

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Papp et al. (2013) studied this question.

synapsesocial.com/papers/6a8232fa90702eaf9393aff4https://doi.org/10.1111/bjd.12214
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Malignant tumours and psoriasis: a follow-up study1999 · 136 citations
  2. 2Safety of Conventional Systemic Agents and Biologic Agents in the Treatment of Psoriasis2009 · 17 citations